MedCanHub: a platform developed by Cellen aimed at reducing barriers of access to unlicensed cannabis-based medicinal products during the COVID-19 pandemic
Lim Zhen Zong, Mala Mawkin, Haggai Sharon, Michael Barnes, Panagiotis Pardalidis, Sarah Marten, Giancarlo Camilleri and Benjamin Viaris de Lesegno
DOI: https://doi.org/10.7861/clinmed.21-2-s29
Clin Med March 2021 Lim Zhen Zong
AImperial College London, London, UK
Mala Mawkin
AImperial College London, London, UK
Haggai Sharon
BGuy's and St Thomas' Pain Management and Neuromodulation Centre, London, UK
Michael Barnes
CMedical Cannabis Clinician Society
Panagiotis Pardalidis
AImperial College London, London, UK
Sarah Marten
DCellen Life Sciences
Giancarlo Camilleri
EAshford and St Peter's NHS Foundation Trust, Surrey, UK
Benjamin Viaris de Lesegno
DCellen Life Sciences
Article Information
vol. 21 no. Suppl 2 29-30
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online June 2, 2021.
Copyright & Usage:
© Royal College of Physicians 2021. All rights reserved.
Author Information
Article usage
Article Tools
MedCanHub: a platform developed by Cellen aimed at reducing barriers of access to unlicensed cannabis-based medicinal products during the COVID-19 pandemic
Lim Zhen Zong, Mala Mawkin, Haggai Sharon, Michael Barnes, Panagiotis Pardalidis, Sarah Marten, Giancarlo Camilleri, Benjamin Viaris de Lesegno
Clinical Medicine Mar 2021, 21 (Suppl 2) 29-30; DOI: 10.7861/clinmed.21-2-s29
Citation Manager Formats
MedCanHub: a platform developed by Cellen aimed at reducing barriers of access to unlicensed cannabis-based medicinal products during the COVID-19 pandemic
Lim Zhen Zong, Mala Mawkin, Haggai Sharon, Michael Barnes, Panagiotis Pardalidis, Sarah Marten, Giancarlo Camilleri, Benjamin Viaris de Lesegno
Clinical Medicine Mar 2021, 21 (Suppl 2) 29-30; DOI: 10.7861/clinmed.21-2-s29
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.